Prostate Cancer Clinical Trials Conducted by United Theranostics

Sponsored By

Trial ID#: CA071-1000 | NCT06764485

Description: The rechARge clinical study is enrolling Bristol-Myers Squibb is now enrolling for an investigational treatment for individuals with metastatic Castration-Resistant Prostate Cancer (mCRPC). The clinical study, called rechRge, is evaluating how well an investigational oral study drug (BMS-986365) works compared to standard treatments for mCRPC

Learn More
Sponsored By

Trial ID#: NCT06533644

Description: LEGION-100: Investigating SYNC-T for Metastatic Prostate Cancer

This clinical trial is enrolling men with advanced prostate cancer that has spread and no longer responds to hormone therapy. SYNC-T Therapy SV-102 combines a procedure that freezes part of a tumor with an infusion of a multi-target drug directly into the tumor, aiming to activate the immune system to fight cancer throughout the body. The trial is evaluating safety, tolerability, and effectiveness.

Learn More